Clinical Trial Update: Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy, safety, and tolerability of oral eletriptan for acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with or Without Aura

Drugs mentioned

• Eletriptan (eletriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine With or Without Aura | Phase 3 | Status: COMPLETED